Table 1.
Clinical data of the studied patients.
| Variable | Levels |
|---|---|
| Age, years | 69 ± 12 |
| Men : women | 15 : 12 |
| IMA, AU | 0.53 ± 0.10 |
| CRP, mg/dL | 0.6 (0.1–5.5) |
| SOFA, points | 2 (0–3) |
| APACHE II, points | 12 (7–16) |
| Body temperature, °C | 36.6 ± 0.7 |
| Mean blood pressure, mmHg | 90 ± 23 |
| Hypotension or use of an inotrope, n | 6 (22%) |
| Heart rate, bpm | 86 ± 24 |
| Respiratory rate, breaths/min | 20 ± 8 |
| A-aDO2 (FiO2 > 50%) or PaO2 (FiO2 < 50%), mmHg | 375 ± 121 |
| pH | 7.4 ± 0.9 |
| Plasma sodium, mmol/L | 139 ± 4 |
| Plasma potassium, mmol/L | 4.3 ± 0.8 |
| Serum creatinine, mol/L | 80 (53–114) |
| Acute renal failure, n | 2 (0.7%) |
| Hematocrit, % | 34.8 ± 6.5 |
| Leukocytes, ×109/L | 6.7 (4.7–12.3) |
| Platelets, ×109/L | 239 ± 86 |
| Bilirubin, mol/L | 12 (9–14) |
| Glasgow coma scale, points | 14.4 ± 1.6 |
| Organ insufficiency or immunodeficiency, n | 13 (48%) |
IMA: ischemia-modified albumin; CRP: C-reactive protein; SOFA: sequential organ failure assessment; APACHE: acute physiology and chronic health evaluation.
Data are expressed as means ± standard deviations, medians (interquartile ranges), or patient numbers.